Linke Zhou

2,4-Dihydroxypyrimidine is a potential urinary metabolite biomarker for diagnosing bipolar disorder

Gut microbiome remodeling induces depressive-like behaviors through a pathway mediated by the host’s metabolism

The Microbiota‐Inflammasome Hypothesis of Major Depression

Amino acid metabolic dysfunction revealed in the prefrontal cortex of a rat model of depression

Divergent Urinary Metabolic Phenotypes between Major Depressive Disorder and Bipolar Disorder Identified by a Combined GC–MS and NMR Spectroscopic Metabonomic Approach

Interactions between the microbiota, immune and nervous systems in health and disease

<p>Metabonomics reveals peripheral and central short-chain fatty acid and amino acid dysfunction in a naturally occurring depressive model of macaques</p>

Sex and gender: modifiers of health, disease, and medicine

The Role of Short-Chain Fatty Acids From Gut Microbiota in Gut-Brain Communication

Current understanding of the human microbiome

Sexual dimorphism in glioma glycolysis underlies sex differences in survival

Gut Microbiota is Altered in Patients with Alzheimer’s Disease

The Controversial Role of Human Gut Lachnospiraceae

A Novel Urinary Metabolite Signature for Diagnosing Major Depressive Disorder

Age- and Sex-Based Hematological and Biochemical Parameters for Macaca fascicularis

Novel urinary biomarkers for diagnosing bipolar disorder